Your email has been successfully added to our mailing list.

×
0.00436699857752495 -0.0270981507823613 -0.0627596017069702 -0.0668421052631579 -0.0622332859174964 -0.0724324324324324 -0.0938833570412518 -0.0682788051209103
Stock impact report

Israel's Therapix gets positive Tourette's drug trial results [Reuters]

THERAPIX BIOSCIENCES LTD AMERICAN DEPOSITARY SHARE (TRPX) 
US:NASDAQ Investor Relations: nasdaq.com/symbol/trpx
Company Research Source: Reuters
Israel's Therapix gets positive Tourette's drug trial results | Reuters Reuters Staff 2 Min Read JERUSALEM (Reuters) - Israel’s Therapix Biosciences announced positive results on Monday from a Phase IIa trial of its cannabinoid-based drug to treat Tourette syndrome (TS), sending its stock price jumping. The clinical-stage pharmaceutical company said in a statement its drug candidate THX-110 “significantly improved symptoms over time” in adults with Tourette’s, which is characterised by involuntary movements and tics. “These results are of particular interest as the pharmacology of THX-110 appears to be distinct from existing medications for TS and may offer a unique option for treating these patients,” Chief Technology Officer Adi Zuloff-Shani said. Current available treatments are frequently inadequate or unsafe, she added. Shares in Therapix were up 26 percent at $6.55 in pre-trading on Nasdaq. The company is waiting for regulatory approval to begin a broader study, expanded to 40 s Show less Read more
Impact Snapshot
Event Time:
TRPX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for TRPX alerts
Opt-in for
TRPX alerts

from News Quantified
Opt-in for
TRPX alerts

from News Quantified